Samsung Electronics has expanded its crucial health tracking Sleep Apnea feature on the Galaxy Watch series, available through the Samsung Health Monitor app, to more countries.
Sleep Apnea, which was introduced with the Galaxy Watch 7 and Watch Ultra models in the US, will now be available in 34 more European markets, in addition to Australia and Singapore.
Sleep Apnea feature
The Sleep Apnea feature is an over-the-counter (OTC), software-only mobile medical application operating on compatible Galaxy Watch series models and Galaxy smartphones. It is intended to detect signs of moderate to severe obstructive sleep apnea in the form of significant breathing disruptions in adult users aged 22 and older over a two-night monitoring period.
The feature is designed for on-demand use and is not intended for individuals previously diagnosed with sleep apnea. Users should not rely on this feature as a substitute for professional diagnosis or treatment by a qualified healthcare provider. The data provided by this device is also not intended to assist clinicians in diagnosing sleep disorders.
The Sleep Apnea feature reflects Samsung’s ongoing commitment to providing users with meaningful insights to support healthy sleep habits. By expanding access to this FDA-authorized feature globally, Samsung is empowering users worldwide to take proactive steps toward better sleep health.
CE Mark Validates Samsung’s Sleep Tool Across Europe
According to the company statement, this growth follows the feature’s receipt of CE (Conformité Européenne or European Conformity) marking for the European Economic Area. The CE marking affirms that Samsung meets the European Union’s health, safety, and environmental protection standards, reinforcing its leadership in sleep technology.
Additionally, the feature was recently approved by Australia’s Therapeutic Goods Administration and Singapore’s Health Sciences Authority.
